The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Dec. 31, 2020
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Amy Hauck Newman, Phoenix, MD (US);

Oluyomi M. Okunola-Bakare, Beltsville, MD (US);

Jianjing Cao, Ellicott City, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); C07C 323/60 (2006.01); A61K 31/135 (2006.01); C07C 317/44 (2006.01); C07C 317/28 (2006.01); C07C 323/25 (2006.01); C07D 295/08 (2006.01); C07D 295/088 (2006.01); C07D 295/108 (2006.01); C07D 295/185 (2006.01);
U.S. Cl.
CPC ...
C07C 323/60 (2013.01); A61K 31/135 (2013.01); A61K 45/06 (2013.01); C07C 317/28 (2013.01); C07C 317/44 (2013.01); C07C 323/25 (2013.01); C07D 295/08 (2013.01); C07D 295/088 (2013.01); C07D 295/108 (2013.01); C07D 295/185 (2013.01); C07C 2601/02 (2017.05);
Abstract

Disclosed herein are bisarylmethylthioacetamides and bisarylmethylthioethylamines useful as inhibitors of monoamine transporters. The compounds are potent and/or selective inhibitors of dopamine (DA), serotonin (5-HT), and/or norepinephrine (NE) reuptake via their respective transporters, DAT, SERT and NET. Also disclosed are methods for eliciting a wake-promoting or cognitive or attention enhancing effect and for treating substance use disorders, attention deficit (hyperactivity) disorder, depressive disorders, bipolar disorder or other neuropsychiatric disorders sleep disorders or cognitive impairment using the compounds.


Find Patent Forward Citations

Loading…